Corrigendum: Association of LRP1B Mutation With Tumor Mutation Burden and Outcomes in Melanoma and Non-small Cell Lung Cancer Patients Treated With Immune Check-Point Blockades

Схожие документы

• Association of LRP1B Mutation With Tumor Mutation Burden and Outcomes in Melanoma and Non-small Cell Lung Cancer Patients Treated With Immune Check-Point Blockades
  по: Chen, Hao, et al.
  Опубликовано: (2019)
• The new identified biomarkers determine sensitivity to immune check-point blockade therapies in melanoma
  по: Chen, Hao, et al.
  Опубликовано: (2019)
• Immunity to X-linked inhibitor of apoptosis protein (XIAP) in malignant melanoma and check-point blockade
  по: Zhou, Jun, et al.
  Опубликовано: (2019)
• Somatic Mutations and Neoepitope Homology in Melanomas Treated with CTLA-4 Blockade
  по: Nathanson, Tavi, et al.
  Опубликовано: (2016)
• Significance of Tumor Mutation Burden in Immune Infiltration and Prognosis in Cutaneous Melanoma
  по: Kang, Kai, et al.
  Опубликовано: (2020)